nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—Risedronate—osteoporosis	0.444	0.668	CbGbCtD
Oxaprozin—CYP2C9—Estropipate—osteoporosis	0.114	0.172	CbGbCtD
Oxaprozin—CYP2C9—Cholecalciferol—osteoporosis	0.0589	0.0886	CbGbCtD
Oxaprozin—CYP2C9—Estradiol—osteoporosis	0.0475	0.0714	CbGbCtD
Oxaprozin—Bifonazole—CYP19A1—osteoporosis	0.000487	0.694	CrCbGaD
Oxaprozin—Anaemia—Zoledronate—osteoporosis	0.000402	0.00122	CcSEcCtD
Oxaprozin—Discomfort—Pamidronate—osteoporosis	0.000401	0.00121	CcSEcCtD
Oxaprozin—Angioedema—Zoledronate—osteoporosis	0.000397	0.0012	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000397	0.0012	CcSEcCtD
Oxaprozin—Abdominal pain—Raloxifene—osteoporosis	0.000396	0.0012	CcSEcCtD
Oxaprozin—Body temperature increased—Raloxifene—osteoporosis	0.000396	0.0012	CcSEcCtD
Oxaprozin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000395	0.00119	CcSEcCtD
Oxaprozin—Urticaria—Ibandronate—osteoporosis	0.000394	0.00119	CcSEcCtD
Oxaprozin—Malaise—Zoledronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Oxaprozin—Body temperature increased—Ibandronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Oxaprozin—Abdominal pain—Ibandronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Oxaprozin—Confusional state—Pamidronate—osteoporosis	0.000392	0.00119	CcSEcCtD
Oxaprozin—Vertigo—Zoledronate—osteoporosis	0.000391	0.00118	CcSEcCtD
Oxaprozin—Syncope—Zoledronate—osteoporosis	0.00039	0.00118	CcSEcCtD
Oxaprozin—Leukopenia—Zoledronate—osteoporosis	0.000389	0.00118	CcSEcCtD
Oxaprozin—Oedema—Pamidronate—osteoporosis	0.000389	0.00118	CcSEcCtD
Oxaprozin—Anaphylactic shock—Pamidronate—osteoporosis	0.000389	0.00118	CcSEcCtD
Oxaprozin—Haemoglobin—Estradiol—osteoporosis	0.000387	0.00117	CcSEcCtD
Oxaprozin—Infection—Pamidronate—osteoporosis	0.000386	0.00117	CcSEcCtD
Oxaprozin—Urticaria—Calcitriol—osteoporosis	0.000386	0.00117	CcSEcCtD
Oxaprozin—Haemorrhage—Estradiol—osteoporosis	0.000385	0.00116	CcSEcCtD
Oxaprozin—Hepatitis—Estradiol—osteoporosis	0.000385	0.00116	CcSEcCtD
Oxaprozin—Palpitations—Zoledronate—osteoporosis	0.000384	0.00116	CcSEcCtD
Oxaprozin—Body temperature increased—Calcitriol—osteoporosis	0.000384	0.00116	CcSEcCtD
Oxaprozin—Abdominal pain—Calcitriol—osteoporosis	0.000384	0.00116	CcSEcCtD
Oxaprozin—Angioedema—Conjugated Estrogens—osteoporosis	0.000383	0.00116	CcSEcCtD
Oxaprozin—Shock—Pamidronate—osteoporosis	0.000382	0.00116	CcSEcCtD
Oxaprozin—Loss of consciousness—Zoledronate—osteoporosis	0.000382	0.00116	CcSEcCtD
Oxaprozin—Thrombocytopenia—Pamidronate—osteoporosis	0.000381	0.00115	CcSEcCtD
Oxaprozin—Vomiting—Etidronic acid—osteoporosis	0.00038	0.00115	CcSEcCtD
Oxaprozin—Tachycardia—Pamidronate—osteoporosis	0.000379	0.00115	CcSEcCtD
Oxaprozin—Rash—Etidronic acid—osteoporosis	0.000377	0.00114	CcSEcCtD
Oxaprozin—Convulsion—Zoledronate—osteoporosis	0.000377	0.00114	CcSEcCtD
Oxaprozin—Dermatitis—Etidronic acid—osteoporosis	0.000377	0.00114	CcSEcCtD
Oxaprozin—Vertigo—Conjugated Estrogens—osteoporosis	0.000376	0.00114	CcSEcCtD
Oxaprozin—Hyperhidrosis—Pamidronate—osteoporosis	0.000376	0.00114	CcSEcCtD
Oxaprozin—Syncope—Conjugated Estrogens—osteoporosis	0.000376	0.00114	CcSEcCtD
Oxaprozin—Hypertension—Zoledronate—osteoporosis	0.000376	0.00114	CcSEcCtD
Oxaprozin—Headache—Etidronic acid—osteoporosis	0.000375	0.00113	CcSEcCtD
Oxaprozin—Asthenia—Estropipate—osteoporosis	0.000371	0.00112	CcSEcCtD
Oxaprozin—Anorexia—Pamidronate—osteoporosis	0.00037	0.00112	CcSEcCtD
Oxaprozin—Palpitations—Conjugated Estrogens—osteoporosis	0.00037	0.00112	CcSEcCtD
Oxaprozin—Insomnia—Risedronate—osteoporosis	0.00037	0.00112	CcSEcCtD
Oxaprozin—Anxiety—Zoledronate—osteoporosis	0.000369	0.00112	CcSEcCtD
Oxaprozin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000368	0.00111	CcSEcCtD
Oxaprozin—Paraesthesia—Risedronate—osteoporosis	0.000367	0.00111	CcSEcCtD
Oxaprozin—Pruritus—Estropipate—osteoporosis	0.000366	0.00111	CcSEcCtD
Oxaprozin—Discomfort—Zoledronate—osteoporosis	0.000366	0.00111	CcSEcCtD
Oxaprozin—Asthenia—Alendronate—osteoporosis	0.000366	0.00111	CcSEcCtD
Oxaprozin—Dyspnoea—Risedronate—osteoporosis	0.000364	0.0011	CcSEcCtD
Oxaprozin—Erythema multiforme—Estradiol—osteoporosis	0.000364	0.0011	CcSEcCtD
Oxaprozin—Hypotension—Pamidronate—osteoporosis	0.000363	0.0011	CcSEcCtD
Oxaprozin—Convulsion—Conjugated Estrogens—osteoporosis	0.000363	0.0011	CcSEcCtD
Oxaprozin—Dry mouth—Zoledronate—osteoporosis	0.000362	0.0011	CcSEcCtD
Oxaprozin—Pruritus—Alendronate—osteoporosis	0.00036	0.00109	CcSEcCtD
Oxaprozin—Dyspepsia—Risedronate—osteoporosis	0.00036	0.00109	CcSEcCtD
Oxaprozin—Tinnitus—Estradiol—osteoporosis	0.000359	0.00109	CcSEcCtD
Oxaprozin—Constipation—Ethinyl Estradiol—osteoporosis	0.000359	0.00108	CcSEcCtD
Oxaprozin—Confusional state—Zoledronate—osteoporosis	0.000358	0.00108	CcSEcCtD
Oxaprozin—Asthenia—Ibandronate—osteoporosis	0.000356	0.00108	CcSEcCtD
Oxaprozin—Anxiety—Conjugated Estrogens—osteoporosis	0.000355	0.00107	CcSEcCtD
Oxaprozin—Nausea—Etidronic acid—osteoporosis	0.000355	0.00107	CcSEcCtD
Oxaprozin—Anaphylactic shock—Zoledronate—osteoporosis	0.000355	0.00107	CcSEcCtD
Oxaprozin—Oedema—Zoledronate—osteoporosis	0.000355	0.00107	CcSEcCtD
Oxaprozin—Diarrhoea—Estropipate—osteoporosis	0.000354	0.00107	CcSEcCtD
Oxaprozin—Infection—Zoledronate—osteoporosis	0.000353	0.00107	CcSEcCtD
Oxaprozin—Insomnia—Pamidronate—osteoporosis	0.000351	0.00106	CcSEcCtD
Oxaprozin—Pruritus—Ibandronate—osteoporosis	0.000351	0.00106	CcSEcCtD
Oxaprozin—Constipation—Risedronate—osteoporosis	0.00035	0.00106	CcSEcCtD
Oxaprozin—Shock—Zoledronate—osteoporosis	0.000349	0.00106	CcSEcCtD
Oxaprozin—Paraesthesia—Pamidronate—osteoporosis	0.000349	0.00106	CcSEcCtD
Oxaprozin—Diarrhoea—Alendronate—osteoporosis	0.000349	0.00105	CcSEcCtD
Oxaprozin—Asthenia—Calcitriol—osteoporosis	0.000348	0.00105	CcSEcCtD
Oxaprozin—Thrombocytopenia—Zoledronate—osteoporosis	0.000348	0.00105	CcSEcCtD
Oxaprozin—Dyspnoea—Pamidronate—osteoporosis	0.000346	0.00105	CcSEcCtD
Oxaprozin—Tachycardia—Zoledronate—osteoporosis	0.000346	0.00105	CcSEcCtD
Oxaprozin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000346	0.00105	CcSEcCtD
Oxaprozin—Somnolence—Pamidronate—osteoporosis	0.000345	0.00104	CcSEcCtD
Oxaprozin—Pruritus—Calcitriol—osteoporosis	0.000344	0.00104	CcSEcCtD
Oxaprozin—Hyperhidrosis—Zoledronate—osteoporosis	0.000343	0.00104	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000343	0.00104	CcSEcCtD
Oxaprozin—Diarrhoea—Raloxifene—osteoporosis	0.000343	0.00104	CcSEcCtD
Oxaprozin—Dyspepsia—Pamidronate—osteoporosis	0.000342	0.00103	CcSEcCtD
Oxaprozin—Dizziness—Estropipate—osteoporosis	0.000342	0.00103	CcSEcCtD
Oxaprozin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000342	0.00103	CcSEcCtD
Oxaprozin—Oedema—Conjugated Estrogens—osteoporosis	0.000342	0.00103	CcSEcCtD
Oxaprozin—Alopecia—Estradiol—osteoporosis	0.00034	0.00103	CcSEcCtD
Oxaprozin—Infection—Conjugated Estrogens—osteoporosis	0.00034	0.00103	CcSEcCtD
Oxaprozin—Diarrhoea—Ibandronate—osteoporosis	0.000339	0.00103	CcSEcCtD
Oxaprozin—Anorexia—Zoledronate—osteoporosis	0.000338	0.00102	CcSEcCtD
Oxaprozin—Decreased appetite—Pamidronate—osteoporosis	0.000338	0.00102	CcSEcCtD
Oxaprozin—Dizziness—Alendronate—osteoporosis	0.000337	0.00102	CcSEcCtD
Oxaprozin—Shock—Conjugated Estrogens—osteoporosis	0.000336	0.00102	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Risedronate—osteoporosis	0.000334	0.00101	CcSEcCtD
Oxaprozin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000334	0.00101	CcSEcCtD
Oxaprozin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000333	0.00101	CcSEcCtD
Oxaprozin—Constipation—Pamidronate—osteoporosis	0.000332	0.00101	CcSEcCtD
Oxaprozin—Diarrhoea—Calcitriol—osteoporosis	0.000332	0.001	CcSEcCtD
Oxaprozin—Hypotension—Zoledronate—osteoporosis	0.000332	0.001	CcSEcCtD
Oxaprozin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000331	0.001	CcSEcCtD
Oxaprozin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000331	0.001	CcSEcCtD
Oxaprozin—Dizziness—Raloxifene—osteoporosis	0.000331	0.001	CcSEcCtD
Oxaprozin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00033	0.000999	CcSEcCtD
Oxaprozin—Flatulence—Estradiol—osteoporosis	0.00033	0.000999	CcSEcCtD
Oxaprozin—Tension—Estradiol—osteoporosis	0.000329	0.000995	CcSEcCtD
Oxaprozin—Vomiting—Estropipate—osteoporosis	0.000329	0.000995	CcSEcCtD
Oxaprozin—Dysgeusia—Estradiol—osteoporosis	0.000328	0.000993	CcSEcCtD
Oxaprozin—Dizziness—Ibandronate—osteoporosis	0.000328	0.000992	CcSEcCtD
Oxaprozin—Rash—Estropipate—osteoporosis	0.000326	0.000986	CcSEcCtD
Oxaprozin—Dermatitis—Estropipate—osteoporosis	0.000326	0.000986	CcSEcCtD
Oxaprozin—Anorexia—Conjugated Estrogens—osteoporosis	0.000326	0.000985	CcSEcCtD
Oxaprozin—Nervousness—Estradiol—osteoporosis	0.000326	0.000985	CcSEcCtD
Oxaprozin—Urticaria—Risedronate—osteoporosis	0.000325	0.000982	CcSEcCtD
Oxaprozin—Headache—Estropipate—osteoporosis	0.000324	0.00098	CcSEcCtD
Oxaprozin—Vomiting—Alendronate—osteoporosis	0.000324	0.00098	CcSEcCtD
Oxaprozin—Abdominal pain—Risedronate—osteoporosis	0.000323	0.000977	CcSEcCtD
Oxaprozin—Body temperature increased—Risedronate—osteoporosis	0.000323	0.000977	CcSEcCtD
Oxaprozin—Rash—Alendronate—osteoporosis	0.000321	0.000972	CcSEcCtD
Oxaprozin—Insomnia—Zoledronate—osteoporosis	0.000321	0.000971	CcSEcCtD
Oxaprozin—Dermatitis—Alendronate—osteoporosis	0.000321	0.000971	CcSEcCtD
Oxaprozin—Feeling abnormal—Pamidronate—osteoporosis	0.00032	0.000969	CcSEcCtD
Oxaprozin—Hypotension—Conjugated Estrogens—osteoporosis	0.000319	0.000966	CcSEcCtD
Oxaprozin—Headache—Alendronate—osteoporosis	0.000319	0.000965	CcSEcCtD
Oxaprozin—Paraesthesia—Zoledronate—osteoporosis	0.000319	0.000964	CcSEcCtD
Oxaprozin—Vomiting—Raloxifene—osteoporosis	0.000319	0.000964	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000318	0.000961	CcSEcCtD
Oxaprozin—Dyspnoea—Zoledronate—osteoporosis	0.000316	0.000957	CcSEcCtD
Oxaprozin—Rash—Raloxifene—osteoporosis	0.000316	0.000956	CcSEcCtD
Oxaprozin—Dermatitis—Raloxifene—osteoporosis	0.000316	0.000955	CcSEcCtD
Oxaprozin—Somnolence—Zoledronate—osteoporosis	0.000316	0.000954	CcSEcCtD
Oxaprozin—Vomiting—Ibandronate—osteoporosis	0.000315	0.000954	CcSEcCtD
Oxaprozin—Tremor—Estradiol—osteoporosis	0.000314	0.00095	CcSEcCtD
Oxaprozin—Headache—Raloxifene—osteoporosis	0.000314	0.000949	CcSEcCtD
Oxaprozin—Rash—Ibandronate—osteoporosis	0.000313	0.000946	CcSEcCtD
Oxaprozin—Dermatitis—Ibandronate—osteoporosis	0.000312	0.000945	CcSEcCtD
Oxaprozin—Dyspepsia—Zoledronate—osteoporosis	0.000312	0.000945	CcSEcCtD
Oxaprozin—Ill-defined disorder—Estradiol—osteoporosis	0.000311	0.000941	CcSEcCtD
Oxaprozin—Headache—Ibandronate—osteoporosis	0.000311	0.00094	CcSEcCtD
Oxaprozin—Insomnia—Conjugated Estrogens—osteoporosis	0.000309	0.000935	CcSEcCtD
Oxaprozin—Vomiting—Calcitriol—osteoporosis	0.000309	0.000934	CcSEcCtD
Oxaprozin—Decreased appetite—Zoledronate—osteoporosis	0.000309	0.000933	CcSEcCtD
Oxaprozin—Nausea—Estropipate—osteoporosis	0.000307	0.000929	CcSEcCtD
Oxaprozin—Abdominal pain—Pamidronate—osteoporosis	0.000307	0.000929	CcSEcCtD
Oxaprozin—Body temperature increased—Pamidronate—osteoporosis	0.000307	0.000929	CcSEcCtD
Oxaprozin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000307	0.000928	CcSEcCtD
Oxaprozin—Angioedema—Estradiol—osteoporosis	0.000306	0.000926	CcSEcCtD
Oxaprozin—Rash—Calcitriol—osteoporosis	0.000306	0.000926	CcSEcCtD
Oxaprozin—Dermatitis—Calcitriol—osteoporosis	0.000306	0.000925	CcSEcCtD
Oxaprozin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000305	0.000922	CcSEcCtD
Oxaprozin—Headache—Calcitriol—osteoporosis	0.000304	0.00092	CcSEcCtD
Oxaprozin—Somnolence—Conjugated Estrogens—osteoporosis	0.000304	0.000919	CcSEcCtD
Oxaprozin—Constipation—Zoledronate—osteoporosis	0.000304	0.000918	CcSEcCtD
Oxaprozin—Nausea—Alendronate—osteoporosis	0.000303	0.000915	CcSEcCtD
Oxaprozin—Malaise—Estradiol—osteoporosis	0.000302	0.000914	CcSEcCtD
Oxaprozin—Vertigo—Estradiol—osteoporosis	0.000301	0.000911	CcSEcCtD
Oxaprozin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000301	0.00091	CcSEcCtD
Oxaprozin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000301	0.00091	CcSEcCtD
Oxaprozin—Syncope—Estradiol—osteoporosis	0.000301	0.000909	CcSEcCtD
Oxaprozin—Nausea—Raloxifene—osteoporosis	0.000298	0.0009	CcSEcCtD
Oxaprozin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000297	0.000899	CcSEcCtD
Oxaprozin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000297	0.000897	CcSEcCtD
Oxaprozin—Palpitations—Estradiol—osteoporosis	0.000296	0.000896	CcSEcCtD
Oxaprozin—Nausea—Ibandronate—osteoporosis	0.000295	0.000891	CcSEcCtD
Oxaprozin—Loss of consciousness—Estradiol—osteoporosis	0.000295	0.000891	CcSEcCtD
Oxaprozin—Asthenia—Risedronate—osteoporosis	0.000293	0.000887	CcSEcCtD
Oxaprozin—Feeling abnormal—Zoledronate—osteoporosis	0.000293	0.000885	CcSEcCtD
Oxaprozin—Constipation—Conjugated Estrogens—osteoporosis	0.000292	0.000884	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Zoledronate—osteoporosis	0.00029	0.000878	CcSEcCtD
Oxaprozin—Hypertension—Estradiol—osteoporosis	0.000289	0.000875	CcSEcCtD
Oxaprozin—Pruritus—Risedronate—osteoporosis	0.000289	0.000875	CcSEcCtD
Oxaprozin—Nausea—Calcitriol—osteoporosis	0.000288	0.000872	CcSEcCtD
Oxaprozin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000287	0.000868	CcSEcCtD
Oxaprozin—Anxiety—Estradiol—osteoporosis	0.000284	0.00086	CcSEcCtD
Oxaprozin—Urticaria—Zoledronate—osteoporosis	0.000282	0.000853	CcSEcCtD
Oxaprozin—Discomfort—Estradiol—osteoporosis	0.000282	0.000853	CcSEcCtD
Oxaprozin—Abdominal pain—Zoledronate—osteoporosis	0.000281	0.000849	CcSEcCtD
Oxaprozin—Body temperature increased—Zoledronate—osteoporosis	0.000281	0.000849	CcSEcCtD
Oxaprozin—Diarrhoea—Risedronate—osteoporosis	0.00028	0.000846	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00028	0.000845	CcSEcCtD
Oxaprozin—Dry mouth—Estradiol—osteoporosis	0.000279	0.000844	CcSEcCtD
Oxaprozin—Asthenia—Pamidronate—osteoporosis	0.000279	0.000843	CcSEcCtD
Oxaprozin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000277	0.000839	CcSEcCtD
Oxaprozin—Confusional state—Estradiol—osteoporosis	0.000276	0.000834	CcSEcCtD
Oxaprozin—Pruritus—Pamidronate—osteoporosis	0.000275	0.000832	CcSEcCtD
Oxaprozin—Oedema—Estradiol—osteoporosis	0.000274	0.000827	CcSEcCtD
Oxaprozin—Anaphylactic shock—Estradiol—osteoporosis	0.000274	0.000827	CcSEcCtD
Oxaprozin—Infection—Estradiol—osteoporosis	0.000272	0.000822	CcSEcCtD
Oxaprozin—Urticaria—Conjugated Estrogens—osteoporosis	0.000272	0.000821	CcSEcCtD
Oxaprozin—Dizziness—Risedronate—osteoporosis	0.00027	0.000818	CcSEcCtD
Oxaprozin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00027	0.000817	CcSEcCtD
Oxaprozin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00027	0.000817	CcSEcCtD
Oxaprozin—Shock—Estradiol—osteoporosis	0.000269	0.000814	CcSEcCtD
Oxaprozin—Tachycardia—Estradiol—osteoporosis	0.000267	0.000808	CcSEcCtD
Oxaprozin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000267	0.000806	CcSEcCtD
Oxaprozin—Diarrhoea—Pamidronate—osteoporosis	0.000266	0.000804	CcSEcCtD
Oxaprozin—Hyperhidrosis—Estradiol—osteoporosis	0.000264	0.0008	CcSEcCtD
Oxaprozin—Rash—Ethinyl Estradiol—osteoporosis	0.000264	0.0008	CcSEcCtD
Oxaprozin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000264	0.000799	CcSEcCtD
Oxaprozin—Headache—Ethinyl Estradiol—osteoporosis	0.000263	0.000794	CcSEcCtD
Oxaprozin—Vomiting—Risedronate—osteoporosis	0.00026	0.000786	CcSEcCtD
Oxaprozin—Rash—Risedronate—osteoporosis	0.000258	0.00078	CcSEcCtD
Oxaprozin—Dermatitis—Risedronate—osteoporosis	0.000258	0.000779	CcSEcCtD
Oxaprozin—Dizziness—Pamidronate—osteoporosis	0.000257	0.000777	CcSEcCtD
Oxaprozin—Headache—Risedronate—osteoporosis	0.000256	0.000775	CcSEcCtD
Oxaprozin—Asthenia—Zoledronate—osteoporosis	0.000255	0.00077	CcSEcCtD
Oxaprozin—Pruritus—Zoledronate—osteoporosis	0.000251	0.00076	CcSEcCtD
Oxaprozin—Nausea—Ethinyl Estradiol—osteoporosis	0.000249	0.000753	CcSEcCtD
Oxaprozin—Insomnia—Estradiol—osteoporosis	0.000247	0.000748	CcSEcCtD
Oxaprozin—Vomiting—Pamidronate—osteoporosis	0.000247	0.000747	CcSEcCtD
Oxaprozin—Paraesthesia—Estradiol—osteoporosis	0.000246	0.000743	CcSEcCtD
Oxaprozin—Asthenia—Conjugated Estrogens—osteoporosis	0.000245	0.000742	CcSEcCtD
Oxaprozin—Rash—Pamidronate—osteoporosis	0.000245	0.000741	CcSEcCtD
Oxaprozin—Dermatitis—Pamidronate—osteoporosis	0.000245	0.00074	CcSEcCtD
Oxaprozin—Dyspnoea—Estradiol—osteoporosis	0.000244	0.000738	CcSEcCtD
Oxaprozin—Headache—Pamidronate—osteoporosis	0.000243	0.000736	CcSEcCtD
Oxaprozin—Somnolence—Estradiol—osteoporosis	0.000243	0.000736	CcSEcCtD
Oxaprozin—Diarrhoea—Zoledronate—osteoporosis	0.000243	0.000735	CcSEcCtD
Oxaprozin—Nausea—Risedronate—osteoporosis	0.000243	0.000734	CcSEcCtD
Oxaprozin—Pruritus—Conjugated Estrogens—osteoporosis	0.000242	0.000731	CcSEcCtD
Oxaprozin—Dyspepsia—Estradiol—osteoporosis	0.000241	0.000728	CcSEcCtD
Oxaprozin—Decreased appetite—Estradiol—osteoporosis	0.000238	0.000719	CcSEcCtD
Oxaprozin—Dizziness—Zoledronate—osteoporosis	0.000235	0.00071	CcSEcCtD
Oxaprozin—Constipation—Estradiol—osteoporosis	0.000234	0.000708	CcSEcCtD
Oxaprozin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000234	0.000707	CcSEcCtD
Oxaprozin—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.000232	0.0621	CbGpPWpGaD
Oxaprozin—Nausea—Pamidronate—osteoporosis	0.000231	0.000698	CcSEcCtD
Oxaprozin—Dizziness—Conjugated Estrogens—osteoporosis	0.000226	0.000684	CcSEcCtD
Oxaprozin—Vomiting—Zoledronate—osteoporosis	0.000226	0.000683	CcSEcCtD
Oxaprozin—Feeling abnormal—Estradiol—osteoporosis	0.000225	0.000682	CcSEcCtD
Oxaprozin—Rash—Zoledronate—osteoporosis	0.000224	0.000677	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Estradiol—osteoporosis	0.000224	0.000677	CcSEcCtD
Oxaprozin—Dermatitis—Zoledronate—osteoporosis	0.000224	0.000676	CcSEcCtD
Oxaprozin—Headache—Zoledronate—osteoporosis	0.000222	0.000673	CcSEcCtD
Oxaprozin—Vomiting—Conjugated Estrogens—osteoporosis	0.000217	0.000657	CcSEcCtD
Oxaprozin—Urticaria—Estradiol—osteoporosis	0.000217	0.000657	CcSEcCtD
Oxaprozin—Abdominal pain—Estradiol—osteoporosis	0.000216	0.000654	CcSEcCtD
Oxaprozin—Body temperature increased—Estradiol—osteoporosis	0.000216	0.000654	CcSEcCtD
Oxaprozin—Rash—Conjugated Estrogens—osteoporosis	0.000216	0.000652	CcSEcCtD
Oxaprozin—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000215	0.0577	CbGpPWpGaD
Oxaprozin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000215	0.000651	CcSEcCtD
Oxaprozin—Methadone—CYP19A1—osteoporosis	0.000215	0.306	CrCbGaD
Oxaprozin—Headache—Conjugated Estrogens—osteoporosis	0.000214	0.000648	CcSEcCtD
Oxaprozin—Nausea—Zoledronate—osteoporosis	0.000211	0.000638	CcSEcCtD
Oxaprozin—Nausea—Conjugated Estrogens—osteoporosis	0.000203	0.000614	CcSEcCtD
Oxaprozin—Asthenia—Estradiol—osteoporosis	0.000196	0.000594	CcSEcCtD
Oxaprozin—Pruritus—Estradiol—osteoporosis	0.000194	0.000585	CcSEcCtD
Oxaprozin—Diarrhoea—Estradiol—osteoporosis	0.000187	0.000566	CcSEcCtD
Oxaprozin—Dizziness—Estradiol—osteoporosis	0.000181	0.000547	CcSEcCtD
Oxaprozin—Vomiting—Estradiol—osteoporosis	0.000174	0.000526	CcSEcCtD
Oxaprozin—Rash—Estradiol—osteoporosis	0.000172	0.000522	CcSEcCtD
Oxaprozin—Dermatitis—Estradiol—osteoporosis	0.000172	0.000521	CcSEcCtD
Oxaprozin—Headache—Estradiol—osteoporosis	0.000171	0.000518	CcSEcCtD
Oxaprozin—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000171	0.0458	CbGpPWpGaD
Oxaprozin—Nausea—Estradiol—osteoporosis	0.000162	0.000491	CcSEcCtD
Oxaprozin—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000131	0.0352	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000122	0.0326	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000104	0.0279	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.77e-05	0.0235	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	7.88e-05	0.0211	CbGpPWpGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	6.2e-05	0.0166	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.68e-05	0.0152	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.61e-05	0.015	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	5.47e-05	0.0147	CbGpPWpGaD
Oxaprozin—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	5.35e-05	0.0143	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	4.97e-05	0.0133	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP27A1—osteoporosis	4.66e-05	0.0125	CbGpPWpGaD
Oxaprozin—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	4.63e-05	0.0124	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	4.61e-05	0.0124	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.61e-05	0.0123	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.6e-05	0.0123	CbGpPWpGaD
Oxaprozin—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	4.25e-05	0.0114	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4.11e-05	0.011	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	3.72e-05	0.00998	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	3.72e-05	0.00997	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	3.66e-05	0.00981	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	3.57e-05	0.00956	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	3.4e-05	0.00912	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	3.14e-05	0.00842	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.11e-05	0.00834	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.99e-05	0.008	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	2.95e-05	0.00792	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.95e-05	0.00791	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.95e-05	0.00789	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	2.83e-05	0.00759	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	2.81e-05	0.00754	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.77e-05	0.00741	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.76e-05	0.0074	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	2.7e-05	0.00724	CbGpPWpGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	2.52e-05	0.00674	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	2.49e-05	0.00668	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.47e-05	0.00662	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	2.45e-05	0.00656	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP19A1—osteoporosis	2.45e-05	0.00655	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.42e-05	0.00648	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	2.41e-05	0.00647	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.34e-05	0.00628	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.29e-05	0.00615	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.24e-05	0.00599	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.97e-05	0.00527	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.94e-05	0.00519	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	1.86e-05	0.005	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—LEP—osteoporosis	1.84e-05	0.00492	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.82e-05	0.00488	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.8e-05	0.00483	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.79e-05	0.00481	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.79e-05	0.00479	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.78e-05	0.00476	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.69e-05	0.00452	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.64e-05	0.00438	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.55e-05	0.00416	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.52e-05	0.00407	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.48e-05	0.00397	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—POMC—osteoporosis	1.47e-05	0.00394	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.45e-05	0.0039	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.42e-05	0.0038	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PKM—osteoporosis	1.39e-05	0.00371	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FDPS—osteoporosis	1.39e-05	0.00371	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	1.35e-05	0.00362	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPD2—osteoporosis	1.31e-05	0.00352	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PGLS—osteoporosis	1.31e-05	0.00352	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SOST—osteoporosis	1.31e-05	0.00352	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PKM—osteoporosis	1.31e-05	0.00352	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.29e-05	0.00344	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.27e-05	0.0034	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ANTXR2—osteoporosis	1.25e-05	0.00334	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PGLS—osteoporosis	1.25e-05	0.00334	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.21e-05	0.00323	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.21e-05	0.00323	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ATIC—osteoporosis	1.2e-05	0.00322	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PNP—osteoporosis	1.2e-05	0.00322	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.2e-05	0.00321	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.19e-05	0.00319	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.18e-05	0.00315	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.17e-05	0.00314	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PKM—osteoporosis	1.1e-05	0.00295	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FDPS—osteoporosis	1.1e-05	0.00295	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	1.09e-05	0.00293	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.07e-05	0.00288	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GSN—osteoporosis	1.06e-05	0.00284	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PGLS—osteoporosis	1.04e-05	0.0028	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPD2—osteoporosis	1.04e-05	0.0028	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.03e-05	0.00277	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CA2—osteoporosis	1.02e-05	0.00274	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—OXCT1—osteoporosis	1.02e-05	0.00274	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MGLL—osteoporosis	9.96e-06	0.00267	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ATIC—osteoporosis	9.54e-06	0.00256	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PNP—osteoporosis	9.54e-06	0.00256	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.4e-06	0.00252	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.39e-06	0.00252	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LRP5—osteoporosis	9.21e-06	0.00247	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—osteoporosis	9.12e-06	0.00244	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	9.1e-06	0.00244	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LRP6—osteoporosis	8.81e-06	0.00236	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	8.67e-06	0.00232	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—osteoporosis	8.49e-06	0.00228	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—IDH2—osteoporosis	8.47e-06	0.00227	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL24—osteoporosis	8.47e-06	0.00227	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LTF—osteoporosis	8.47e-06	0.00227	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CA2—osteoporosis	8.11e-06	0.00217	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—OXCT1—osteoporosis	8.11e-06	0.00217	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.99e-06	0.00214	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP27A1—osteoporosis	7.96e-06	0.00213	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MGLL—osteoporosis	7.91e-06	0.00212	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ACP5—osteoporosis	7.75e-06	0.00208	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—osteoporosis	7.73e-06	0.00207	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.65e-06	0.00205	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.46e-06	0.002	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ACP5—osteoporosis	7.34e-06	0.00197	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PKM—osteoporosis	7.29e-06	0.00195	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FDPS—osteoporosis	7.29e-06	0.00195	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TPI1—osteoporosis	7.2e-06	0.00193	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPD2—osteoporosis	6.91e-06	0.00185	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PGLS—osteoporosis	6.91e-06	0.00185	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—osteoporosis	6.85e-06	0.00184	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TPI1—osteoporosis	6.83e-06	0.00183	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—P4HB—osteoporosis	6.77e-06	0.00181	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—IDH2—osteoporosis	6.72e-06	0.0018	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GAPDH—osteoporosis	6.65e-06	0.00178	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RAP1A—osteoporosis	6.47e-06	0.00173	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—P4HB—osteoporosis	6.42e-06	0.00172	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP27A1—osteoporosis	6.32e-06	0.00169	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PNP—osteoporosis	6.32e-06	0.00169	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ATIC—osteoporosis	6.32e-06	0.00169	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GAPDH—osteoporosis	6.3e-06	0.00169	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.2e-06	0.00166	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.19e-06	0.00166	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACP5—osteoporosis	6.15e-06	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.07e-06	0.00163	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NFATC1—osteoporosis	5.99e-06	0.0016	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—DKK1—osteoporosis	5.94e-06	0.00159	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.78e-06	0.00155	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—WNT1—osteoporosis	5.72e-06	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TPI1—osteoporosis	5.72e-06	0.00153	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.64e-06	0.00151	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGA—osteoporosis	5.56e-06	0.00149	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—P4HB—osteoporosis	5.37e-06	0.00144	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CA2—osteoporosis	5.37e-06	0.00144	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—OXCT1—osteoporosis	5.37e-06	0.00144	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GAPDH—osteoporosis	5.28e-06	0.00141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MGLL—osteoporosis	5.24e-06	0.0014	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ENO1—osteoporosis	5.23e-06	0.0014	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PSMA5—osteoporosis	5.16e-06	0.00138	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PSMA2—osteoporosis	5.16e-06	0.00138	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RAP1A—osteoporosis	5.14e-06	0.00138	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ENO1—osteoporosis	4.96e-06	0.00133	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.94e-06	0.00132	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PSMA2—osteoporosis	4.89e-06	0.00131	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PSMA5—osteoporosis	4.89e-06	0.00131	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CALCA—osteoporosis	4.55e-06	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.48e-06	0.0012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH2—osteoporosis	4.45e-06	0.00119	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP27A1—osteoporosis	4.19e-06	0.00112	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP19A1—osteoporosis	4.18e-06	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ENO1—osteoporosis	4.15e-06	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KL—osteoporosis	4.14e-06	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PSMA2—osteoporosis	4.09e-06	0.0011	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PSMA5—osteoporosis	4.09e-06	0.0011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACP5—osteoporosis	4.07e-06	0.00109	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.02e-06	0.00108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TPI1—osteoporosis	3.79e-06	0.00101	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—P4HB—osteoporosis	3.56e-06	0.000954	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GAPDH—osteoporosis	3.49e-06	0.000936	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ADCY5—osteoporosis	3.42e-06	0.000916	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPX1—osteoporosis	3.41e-06	0.000912	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RAP1A—osteoporosis	3.4e-06	0.000912	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP19A1—osteoporosis	3.32e-06	0.00089	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADCY5—osteoporosis	3.24e-06	0.000868	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—osteoporosis	3.14e-06	0.000842	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—osteoporosis	2.98e-06	0.000798	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.97e-06	0.000795	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IRS2—osteoporosis	2.83e-06	0.000759	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ENO1—osteoporosis	2.75e-06	0.000737	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ADCY5—osteoporosis	2.71e-06	0.000727	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PSMA2—osteoporosis	2.71e-06	0.000726	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PSMA5—osteoporosis	2.71e-06	0.000726	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPX1—osteoporosis	2.7e-06	0.000724	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—osteoporosis	2.51e-06	0.000673	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—osteoporosis	2.5e-06	0.000668	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IRS1—osteoporosis	2.47e-06	0.000663	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6R—osteoporosis	2.32e-06	0.000623	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.2e-06	0.000589	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—osteoporosis	2e-06	0.000535	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADCY5—osteoporosis	1.8e-06	0.000481	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX1—osteoporosis	1.79e-06	0.00048	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—osteoporosis	1.65e-06	0.000443	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—osteoporosis	1.38e-06	0.000369	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—osteoporosis	1.37e-06	0.000368	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—osteoporosis	1.32e-06	0.000354	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—osteoporosis	1.04e-06	0.000277	CbGpPWpGaD
